Business
-
According to MannKind Corporation, it has completely resolved arbitration initiated by a lawsuit filed by its former Senior Director – GCP – Regulatory Affairs, John Arditi, in 2010. Arditi, who had been responsible for MannKind’s… Read more . . .
-
US Patent No. 8,076,290 regarding stabilized formulations of parathyroid hormone (PTH) and PTH peptide analogs for various means of delivery, including intranasal delivery, has been awarded to Aegis Therapeutics. PTH and PTH peptide analogs such… Read more . . .
-
The United States Patent and Trademark Office has issued US Patent No. 8,071,127 regarding formulations of inhaled liposomal and free ciprofloxacin to Aradigm Corporation. The patent covers the company’s lead candidate, Pulmaquin dual release ciprofloxacin… Read more . . .
-
A report from research firm Decision Resources predicts no growth in the asthma drug market through 2020, in large part due to incursions by generics and greater competition. According to the company, “The overall asthma… Read more . . .
-
Merck and NanoBio will conduct preclinical studies to evaluate a vaccine combining Merck’s respiratory syncyctial virus (RSV) antigen with NanoBio’s NanoStat adjuvant. NanoBio has already conducted studies that showed the induction of immunity by a… Read more . . .
-
Swedish pharma company Meda released a statement regarding a new patent for its Astepro nasal spray that reads in its entirety: “The United States Patent and Trademark Office (USPTO) today issued a patent related to… Read more . . .
-
Consort Medical, parent company of device developer and manufacturer Bespak, reports “strong volume growth” for Bespak’s inhaler business for the six months ending October 31, 2011. Bespak revenues were up 17% from 2010, with operating… Read more . . .
-
Acacia Research, a California company frequently described as a “patent troll,” says that it has acquired 13 patents for inhaler technology from “a major medical company.” Company CEO Paul Ryan said, “Acacia continues to increase… Read more . . .
-
Bloomberg has published an article about GSK’s overhaul of its R&D organization that describes former head of the allergic inflammation discovery performance unit Roberto Solari as “one of the casualties of the company’s new approach… Read more . . .
-
AstraZeneca has asked the New Zealand High Court to review a decision by Pharmac, the government drug purchasing agency, to reduce its subsidy for the Symbicort Turbuhaler to achieve pricing parity with GSK’s Seretide (Advair)… Read more . . .
Featured event:
Upcoming Events
Sponsored by Intertek,, hosts of
The Inhaled & Nasal Biologics | DNA Forum
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
October 14-October 15: Advancing Bioequivalence Frameworks for Inhalation and Nasal Drug Products: Optimizing In Vitro, In Vivo, and In Silico Methods, Rockville, MD, USA
October 19-October 20: MVIC Autumn Training 2026, Lund, Sweden
October 21-October 22: MVIC Symposium, Lund, Sweden
October 28-October 30: Deutches Aerosol Therapie Symposium (DATS), Marburg, Germany
November 10-November 11: Rescon Europe 2026, Porto, Portugal